CA2692803A1 - Compositions, procedes et trousses pour le diagnostic de transporteurs de mutations dans les genes brca1 et brca2 et le diagnostic precoce de troubles cancereux associes a des mutations dans les genes brca1 et brca2 - Google Patents
Compositions, procedes et trousses pour le diagnostic de transporteurs de mutations dans les genes brca1 et brca2 et le diagnostic precoce de troubles cancereux associes a des mutations dans les genes brca1 et brca2 Download PDFInfo
- Publication number
- CA2692803A1 CA2692803A1 CA 2692803 CA2692803A CA2692803A1 CA 2692803 A1 CA2692803 A1 CA 2692803A1 CA 2692803 CA2692803 CA 2692803 CA 2692803 A CA2692803 A CA 2692803A CA 2692803 A1 CA2692803 A1 CA 2692803A1
- Authority
- CA
- Canada
- Prior art keywords
- protein
- expression
- genes
- gene
- detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 597
- 230000035772 mutation Effects 0.000 title claims abstract description 113
- 238000000034 method Methods 0.000 title claims abstract description 85
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 239000000969 carrier Substances 0.000 title abstract description 67
- 238000003745 diagnosis Methods 0.000 title abstract description 11
- 238000013399 early diagnosis Methods 0.000 title description 5
- 239000003550 marker Substances 0.000 claims abstract description 267
- 230000014509 gene expression Effects 0.000 claims abstract description 218
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 128
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 100
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 100
- 102000036365 BRCA1 Human genes 0.000 claims abstract description 97
- 238000001514 detection method Methods 0.000 claims abstract description 65
- 238000012360 testing method Methods 0.000 claims abstract description 48
- 208000026310 Breast neoplasm Diseases 0.000 claims abstract description 41
- 108700010154 BRCA2 Genes Proteins 0.000 claims abstract description 35
- 150000001413 amino acids Chemical class 0.000 claims abstract description 34
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 32
- 108700040618 BRCA1 Genes Proteins 0.000 claims abstract description 31
- 206010033128 Ovarian cancer Diseases 0.000 claims abstract description 20
- 239000000523 sample Substances 0.000 claims description 160
- 102000004169 proteins and genes Human genes 0.000 claims description 93
- 238000003556 assay Methods 0.000 claims description 74
- 101150072950 BRCA1 gene Proteins 0.000 claims description 73
- 108700020463 BRCA1 Proteins 0.000 claims description 70
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 67
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 58
- 229920001184 polypeptide Polymers 0.000 claims description 52
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 52
- 102100038662 E3 ubiquitin-protein ligase SMURF2 Human genes 0.000 claims description 50
- 108091034117 Oligonucleotide Proteins 0.000 claims description 47
- 102100023147 E3 ubiquitin-protein ligase MARCHF7 Human genes 0.000 claims description 46
- 101000978673 Homo sapiens E3 ubiquitin-protein ligase MARCHF7 Proteins 0.000 claims description 45
- 102100033417 Glucocorticoid receptor Human genes 0.000 claims description 44
- 102100020981 Regulator of G-protein signaling 16 Human genes 0.000 claims description 44
- 239000013068 control sample Substances 0.000 claims description 43
- 101000744718 Homo sapiens YTH domain-containing family protein 3 Proteins 0.000 claims description 42
- 102100039953 Interferon-induced protein 44-like Human genes 0.000 claims description 42
- 102100028338 Mid1-interacting protein 1 Human genes 0.000 claims description 42
- 101710148341 Regulator of G-protein signaling 16 Proteins 0.000 claims description 42
- 102100039674 YTH domain-containing family protein 3 Human genes 0.000 claims description 42
- 102100035921 Arginine/serine-rich protein PNISR Human genes 0.000 claims description 41
- 102100029776 Eukaryotic translation initiation factor 3 subunit D Human genes 0.000 claims description 41
- 101000936433 Homo sapiens Methylglutaconyl-CoA hydratase, mitochondrial Proteins 0.000 claims description 41
- 101001061915 Homo sapiens Rab3 GTPase-activating protein catalytic subunit Proteins 0.000 claims description 41
- 102100027392 Methylglutaconyl-CoA hydratase, mitochondrial Human genes 0.000 claims description 41
- 102100029548 Rab3 GTPase-activating protein catalytic subunit Human genes 0.000 claims description 41
- 102100024481 Signal transducer and activator of transcription 5A Human genes 0.000 claims description 41
- 102100034108 DnaJ homolog subfamily C member 12 Human genes 0.000 claims description 40
- 101000870234 Homo sapiens DnaJ homolog subfamily C member 12 Proteins 0.000 claims description 40
- 102100035075 ETS-related transcription factor Elf-1 Human genes 0.000 claims description 39
- 101000877395 Homo sapiens ETS-related transcription factor Elf-1 Proteins 0.000 claims description 39
- 101710142533 Interferon-induced protein 44-like Proteins 0.000 claims description 38
- 101710173976 Arginine/serine-rich protein PNISR Proteins 0.000 claims description 37
- 239000002773 nucleotide Substances 0.000 claims description 33
- 125000003729 nucleotide group Chemical group 0.000 claims description 33
- 210000004027 cell Anatomy 0.000 claims description 30
- 101000664952 Homo sapiens E3 ubiquitin-protein ligase SMURF2 Proteins 0.000 claims description 29
- 108010018525 NFATC Transcription Factors Proteins 0.000 claims description 29
- 101000578877 Homo sapiens Mid1-interacting protein 1 Proteins 0.000 claims description 28
- -1 70kDa Proteins 0.000 claims description 27
- 238000009396 hybridization Methods 0.000 claims description 27
- 102100028831 28S ribosomal protein S6, mitochondrial Human genes 0.000 claims description 25
- 101000858474 Homo sapiens 28S ribosomal protein S6, mitochondrial Proteins 0.000 claims description 25
- 102100035413 Nuclear factor of activated T-cells 5 Human genes 0.000 claims description 24
- 108010016777 Cyclin-Dependent Kinase Inhibitor p27 Proteins 0.000 claims description 23
- 101000926939 Homo sapiens Glucocorticoid receptor Proteins 0.000 claims description 23
- 101000674040 Homo sapiens Serine-tRNA ligase, mitochondrial Proteins 0.000 claims description 23
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 23
- 108010029477 STAT5 Transcription Factor Proteins 0.000 claims description 23
- 101001051706 Homo sapiens Ribosomal protein S6 kinase beta-1 Proteins 0.000 claims description 22
- 102100024908 Ribosomal protein S6 kinase beta-1 Human genes 0.000 claims description 22
- 108010030161 Serine-tRNA ligase Proteins 0.000 claims description 22
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 22
- 101710109090 E3 ubiquitin-protein ligase SMURF2 Proteins 0.000 claims description 21
- 101001012766 Homo sapiens Eukaryotic translation initiation factor 3 subunit D Proteins 0.000 claims description 21
- 108010093175 Member 2 Group A Nuclear Receptor Subfamily 4 Proteins 0.000 claims description 21
- 101150058731 STAT5A gene Proteins 0.000 claims description 21
- 108050006769 Nuclear factor of activated T-cells 5 Proteins 0.000 claims description 20
- 108010034782 Ribosomal Protein S6 Kinases Proteins 0.000 claims description 20
- 102000009738 Ribosomal Protein S6 Kinases Human genes 0.000 claims description 20
- 101100501193 Schizosaccharomyces pombe (strain 972 / ATCC 24843) moe1 gene Proteins 0.000 claims description 20
- 230000003321 amplification Effects 0.000 claims description 20
- 210000000481 breast Anatomy 0.000 claims description 20
- 101150001367 eif3d gene Proteins 0.000 claims description 20
- 102000002559 Member 2 Group A Nuclear Receptor Subfamily 4 Human genes 0.000 claims description 19
- 101000914063 Eucalyptus globulus Leafy/floricaula homolog FL1 Proteins 0.000 claims description 18
- 101000881764 Homo sapiens Transcription elongation factor 1 homolog Proteins 0.000 claims description 18
- 238000002493 microarray Methods 0.000 claims description 17
- 238000003753 real-time PCR Methods 0.000 claims description 16
- 230000001965 increasing effect Effects 0.000 claims description 15
- 101710203190 Mid1-interacting protein 1 Proteins 0.000 claims description 14
- 239000012472 biological sample Substances 0.000 claims description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims description 14
- 102100033233 Cyclin-dependent kinase inhibitor 1B Human genes 0.000 claims description 10
- 238000001262 western blot Methods 0.000 claims description 10
- 238000002965 ELISA Methods 0.000 claims description 9
- 206010060862 Prostate cancer Diseases 0.000 claims description 9
- 238000003018 immunoassay Methods 0.000 claims description 9
- 230000000052 comparative effect Effects 0.000 claims description 8
- 238000007901 in situ hybridization Methods 0.000 claims description 8
- 239000013642 negative control Substances 0.000 claims description 8
- 210000000496 pancreas Anatomy 0.000 claims description 8
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 8
- 239000013641 positive control Substances 0.000 claims description 8
- 210000001519 tissue Anatomy 0.000 claims description 8
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 claims description 7
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims description 7
- 238000003384 imaging method Methods 0.000 claims description 7
- 230000002055 immunohistochemical effect Effects 0.000 claims description 7
- 101000944361 Homo sapiens Cyclin-dependent kinase inhibitor 1B Proteins 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 208000021045 exocrine pancreatic carcinoma Diseases 0.000 claims description 6
- 238000000338 in vitro Methods 0.000 claims description 6
- 201000001514 prostate carcinoma Diseases 0.000 claims description 6
- 238000011002 quantification Methods 0.000 claims description 6
- 101150008921 Brca2 gene Proteins 0.000 claims description 5
- 230000005778 DNA damage Effects 0.000 claims description 5
- 231100000277 DNA damage Toxicity 0.000 claims description 5
- 238000004113 cell culture Methods 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 5
- 230000028327 secretion Effects 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims description 4
- 210000000056 organ Anatomy 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 108700020462 BRCA2 Proteins 0.000 claims description 2
- 102000052609 BRCA2 Human genes 0.000 claims description 2
- 238000009007 Diagnostic Kit Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 230000000968 intestinal effect Effects 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000001672 ovary Anatomy 0.000 claims description 2
- 230000000241 respiratory effect Effects 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 102100040597 Serine-tRNA ligase, mitochondrial Human genes 0.000 claims 8
- 101001000549 Homo sapiens Arginine/serine-rich protein PNISR Proteins 0.000 claims 4
- 101000959664 Homo sapiens Interferon-induced protein 44-like Proteins 0.000 claims 4
- 102000001712 STAT5 Transcription Factor Human genes 0.000 claims 4
- 206010036790 Productive cough Diseases 0.000 claims 1
- 210000000601 blood cell Anatomy 0.000 claims 1
- 210000003608 fece Anatomy 0.000 claims 1
- 210000004880 lymph fluid Anatomy 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 210000003802 sputum Anatomy 0.000 claims 1
- 208000024794 sputum Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 abstract description 36
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract description 10
- 230000002611 ovarian Effects 0.000 abstract description 6
- 235000018102 proteins Nutrition 0.000 description 87
- 239000000047 product Substances 0.000 description 68
- 238000003752 polymerase chain reaction Methods 0.000 description 40
- 102100040516 Serine-tRNA ligase, cytoplasmic Human genes 0.000 description 35
- 206010028980 Neoplasm Diseases 0.000 description 27
- 102000002673 NFATC Transcription Factors Human genes 0.000 description 25
- 201000011510 cancer Diseases 0.000 description 23
- 229940024606 amino acid Drugs 0.000 description 22
- 102000040430 polynucleotide Human genes 0.000 description 22
- 108091033319 polynucleotide Proteins 0.000 description 22
- 235000001014 amino acid Nutrition 0.000 description 21
- 239000003795 chemical substances by application Substances 0.000 description 21
- 239000002157 polynucleotide Substances 0.000 description 21
- 208000035475 disorder Diseases 0.000 description 20
- 102000000577 Cyclin-Dependent Kinase Inhibitor p27 Human genes 0.000 description 19
- 101000674278 Homo sapiens Serine-tRNA ligase, cytoplasmic Proteins 0.000 description 19
- 230000006870 function Effects 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 18
- 238000004458 analytical method Methods 0.000 description 17
- 230000027455 binding Effects 0.000 description 17
- 210000004698 lymphocyte Anatomy 0.000 description 17
- 108020004999 messenger RNA Proteins 0.000 description 17
- 230000001105 regulatory effect Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 239000012634 fragment Substances 0.000 description 16
- 239000002299 complementary DNA Substances 0.000 description 15
- 102100033731 40S ribosomal protein S9 Human genes 0.000 description 14
- 108091093088 Amplicon Proteins 0.000 description 14
- 102100032510 Heat shock protein HSP 90-beta Human genes 0.000 description 14
- 101001016856 Homo sapiens Heat shock protein HSP 90-beta Proteins 0.000 description 14
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 108020004463 18S ribosomal RNA Proteins 0.000 description 13
- 101000657066 Homo sapiens 40S ribosomal protein S9 Proteins 0.000 description 13
- 230000001747 exhibiting effect Effects 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- 230000001413 cellular effect Effects 0.000 description 11
- 108010085238 Actins Proteins 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 230000001419 dependent effect Effects 0.000 description 10
- 230000003993 interaction Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 230000037361 pathway Effects 0.000 description 10
- 102000005962 receptors Human genes 0.000 description 10
- 108020003175 receptors Proteins 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 230000000295 complement effect Effects 0.000 description 9
- 239000000975 dye Substances 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 238000013518 transcription Methods 0.000 description 9
- 230000035897 transcription Effects 0.000 description 9
- 108091007743 BRCA1/2 Proteins 0.000 description 8
- 206010064571 Gene mutation Diseases 0.000 description 8
- 102100021186 Granulysin Human genes 0.000 description 8
- 102100022828 Retinoblastoma-like protein 2 Human genes 0.000 description 8
- 239000000427 antigen Substances 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000010839 reverse transcription Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 206010071981 BRCA2 gene mutation Diseases 0.000 description 7
- 101710168479 Granulysin Proteins 0.000 description 7
- 201000008275 breast carcinoma Diseases 0.000 description 7
- 230000004663 cell proliferation Effects 0.000 description 7
- 231100000517 death Toxicity 0.000 description 7
- 238000002405 diagnostic procedure Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 210000002950 fibroblast Anatomy 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 230000026731 phosphorylation Effects 0.000 description 7
- 238000006366 phosphorylation reaction Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000011664 signaling Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 102000007469 Actins Human genes 0.000 description 6
- 102100034613 Annexin A2 Human genes 0.000 description 6
- 108090000668 Annexin A2 Proteins 0.000 description 6
- 230000033616 DNA repair Effects 0.000 description 6
- 230000004568 DNA-binding Effects 0.000 description 6
- 108010042283 HSP40 Heat-Shock Proteins Proteins 0.000 description 6
- 102000004447 HSP40 Heat-Shock Proteins Human genes 0.000 description 6
- 102000000588 Interleukin-2 Human genes 0.000 description 6
- 108010002350 Interleukin-2 Proteins 0.000 description 6
- 102000003960 Ligases Human genes 0.000 description 6
- 108090000364 Ligases Proteins 0.000 description 6
- 102100034606 Serine hydroxymethyltransferase, mitochondrial Human genes 0.000 description 6
- 210000001744 T-lymphocyte Anatomy 0.000 description 6
- 238000003491 array Methods 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 230000034994 death Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000003862 glucocorticoid Substances 0.000 description 6
- 230000022983 regulation of cell cycle Effects 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 5
- 108020004635 Complementary DNA Proteins 0.000 description 5
- 102000016736 Cyclin Human genes 0.000 description 5
- 108050006400 Cyclin Proteins 0.000 description 5
- 108010068237 Cyclin H Proteins 0.000 description 5
- 108010068106 Cyclin T Proteins 0.000 description 5
- 102100036883 Cyclin-H Human genes 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 5
- 102100034176 Glutathione-specific gamma-glutamylcyclotransferase 1 Human genes 0.000 description 5
- 102100036241 HLA class II histocompatibility antigen, DQ beta 1 chain Human genes 0.000 description 5
- 101000943584 Homo sapiens Glutathione-specific gamma-glutamylcyclotransferase 1 Proteins 0.000 description 5
- 102100022676 Nuclear receptor subfamily 4 group A member 2 Human genes 0.000 description 5
- 101710163270 Nuclease Proteins 0.000 description 5
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 5
- 239000013614 RNA sample Substances 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000003757 reverse transcription PCR Methods 0.000 description 5
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 4
- 206010071980 BRCA1 gene mutation Diseases 0.000 description 4
- 102100024112 Cyclin-T2 Human genes 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 101001003140 Homo sapiens Interleukin-15 receptor subunit alpha Proteins 0.000 description 4
- 102000003812 Interleukin-15 Human genes 0.000 description 4
- 108090000172 Interleukin-15 Proteins 0.000 description 4
- 102100020789 Interleukin-15 receptor subunit alpha Human genes 0.000 description 4
- 108010009491 Lysosomal-Associated Membrane Protein 2 Proteins 0.000 description 4
- 102100038225 Lysosome-associated membrane glycoprotein 2 Human genes 0.000 description 4
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 4
- 101710084636 Serine hydroxymethyltransferase Proteins 0.000 description 4
- 101710099809 Serine hydroxymethyltransferase, cytosolic Proteins 0.000 description 4
- 101710087362 Serine hydroxymethyltransferase, mitochondrial Proteins 0.000 description 4
- 102100024548 Tensin-3 Human genes 0.000 description 4
- 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 4
- 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 231100000504 carcinogenesis Toxicity 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000012707 chemical precursor Substances 0.000 description 4
- 108010072268 cyclin-dependent kinase-activating kinase Proteins 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 238000001114 immunoprecipitation Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000009758 senescence Effects 0.000 description 4
- 230000019491 signal transduction Effects 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 108091035539 telomere Proteins 0.000 description 4
- 210000003411 telomere Anatomy 0.000 description 4
- 102000055501 telomere Human genes 0.000 description 4
- XUHRVZXFBWDCFB-QRTDKPMLSA-N (3R)-4-[[(3S,6S,9S,12R,15S,18R,21R,24R,27R,28R)-12-(3-amino-3-oxopropyl)-6-[(2S)-butan-2-yl]-3-(2-carboxyethyl)-18-(hydroxymethyl)-28-methyl-9,15,21,24-tetrakis(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-3-[[(2R)-2-[[(3S)-3-hydroxydecanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoic acid Chemical compound CCCCCCC[C@H](O)CC(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC1=O)[C@@H](C)CC XUHRVZXFBWDCFB-QRTDKPMLSA-N 0.000 description 3
- 102100023818 ADP-ribosylation factor 3 Human genes 0.000 description 3
- 101710139744 ADP-ribosylation factor 3 Proteins 0.000 description 3
- 101710159080 Aconitate hydratase A Proteins 0.000 description 3
- 101710159078 Aconitate hydratase B Proteins 0.000 description 3
- 102100034452 Alternative prion protein Human genes 0.000 description 3
- 102100021631 B-cell lymphoma 6 protein Human genes 0.000 description 3
- 206010006298 Breast pain Diseases 0.000 description 3
- 102100024457 Cyclin-dependent kinase 9 Human genes 0.000 description 3
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 3
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 3
- 108010036466 E2F2 Transcription Factor Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108700039887 Essential Genes Proteins 0.000 description 3
- 108091006027 G proteins Proteins 0.000 description 3
- 102000030782 GTP binding Human genes 0.000 description 3
- 108091000058 GTP-Binding Proteins 0.000 description 3
- 102100032863 General transcription factor IIH subunit 3 Human genes 0.000 description 3
- 108090000079 Glucocorticoid Receptors Proteins 0.000 description 3
- 208000033640 Hereditary breast cancer Diseases 0.000 description 3
- 101000980930 Homo sapiens Cyclin-dependent kinase 9 Proteins 0.000 description 3
- 101000666405 Homo sapiens General transcription factor IIH subunit 1 Proteins 0.000 description 3
- 101000655398 Homo sapiens General transcription factor IIH subunit 2 Proteins 0.000 description 3
- 101000655391 Homo sapiens General transcription factor IIH subunit 3 Proteins 0.000 description 3
- 101000655406 Homo sapiens General transcription factor IIH subunit 4 Proteins 0.000 description 3
- 101000655402 Homo sapiens General transcription factor IIH subunit 5 Proteins 0.000 description 3
- 101001109698 Homo sapiens Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 description 3
- 101001067604 Homo sapiens Serine hydroxymethyltransferase, mitochondrial Proteins 0.000 description 3
- 101000904499 Homo sapiens Transcription regulator protein BACH2 Proteins 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 208000005726 Inflammatory Breast Neoplasms Diseases 0.000 description 3
- 206010021980 Inflammatory carcinoma of the breast Diseases 0.000 description 3
- 108010044467 Isoenzymes Proteins 0.000 description 3
- 102000014944 Lysosome-Associated Membrane Glycoproteins Human genes 0.000 description 3
- 108010064171 Lysosome-Associated Membrane Glycoproteins Proteins 0.000 description 3
- 208000006662 Mastodynia Diseases 0.000 description 3
- 102100023123 Mucin-16 Human genes 0.000 description 3
- 238000000636 Northern blotting Methods 0.000 description 3
- 108091000080 Phosphotransferase Proteins 0.000 description 3
- 108010012271 Positive Transcriptional Elongation Factor B Proteins 0.000 description 3
- 102000019014 Positive Transcriptional Elongation Factor B Human genes 0.000 description 3
- 102100034186 RING finger protein 11 Human genes 0.000 description 3
- 102000044126 RNA-Binding Proteins Human genes 0.000 description 3
- 101710105008 RNA-binding protein Proteins 0.000 description 3
- 108010003494 Retinoblastoma-Like Protein p130 Proteins 0.000 description 3
- 102000003861 Ribosomal protein S6 Human genes 0.000 description 3
- 108090000221 Ribosomal protein S6 Proteins 0.000 description 3
- 101710100619 Tensin-3 Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102100024024 Transcription factor E2F2 Human genes 0.000 description 3
- 102100023998 Transcription regulator protein BACH2 Human genes 0.000 description 3
- 108090000848 Ubiquitin Proteins 0.000 description 3
- 102000044159 Ubiquitin Human genes 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 210000004899 c-terminal region Anatomy 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 238000007405 data analysis Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 208000025581 hereditary breast carcinoma Diseases 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 201000004653 inflammatory breast carcinoma Diseases 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000003499 nucleic acid array Methods 0.000 description 3
- 201000002528 pancreatic cancer Diseases 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 102000020233 phosphotransferase Human genes 0.000 description 3
- 238000004393 prognosis Methods 0.000 description 3
- 108091006106 transcriptional activators Proteins 0.000 description 3
- 230000034512 ubiquitination Effects 0.000 description 3
- 238000010798 ubiquitination Methods 0.000 description 3
- 230000003827 upregulation Effects 0.000 description 3
- 102100040768 60S ribosomal protein L32 Human genes 0.000 description 2
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 2
- 102000004149 Annexin A2 Human genes 0.000 description 2
- 102100037140 BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like Human genes 0.000 description 2
- 108700000712 BH3 Interacting Domain Death Agonist Proteins 0.000 description 2
- 102100035740 BH3-interacting domain death agonist Human genes 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 102100026658 Cathepsin W Human genes 0.000 description 2
- 101710163595 Chaperone protein DnaK Proteins 0.000 description 2
- 102100035595 Cohesin subunit SA-2 Human genes 0.000 description 2
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 2
- 102000002435 Cyclin T Human genes 0.000 description 2
- 102100023044 Cytosolic acyl coenzyme A thioester hydrolase Human genes 0.000 description 2
- 101710152190 Cytosolic acyl coenzyme A thioester hydrolase Proteins 0.000 description 2
- 102100020977 DnaJ homolog subfamily A member 1 Human genes 0.000 description 2
- 208000006402 Ductal Carcinoma Diseases 0.000 description 2
- 108010089790 Eukaryotic Initiation Factor-3 Proteins 0.000 description 2
- 102000008016 Eukaryotic Initiation Factor-3 Human genes 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102100023122 Glycylpeptide N-tetradecanoyltransferase 2 Human genes 0.000 description 2
- 108010065026 HLA-DQB1 antigen Proteins 0.000 description 2
- 101710178376 Heat shock 70 kDa protein Proteins 0.000 description 2
- 102100040407 Heat shock 70 kDa protein 1B Human genes 0.000 description 2
- 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 description 2
- 102100031624 Heat shock protein 105 kDa Human genes 0.000 description 2
- 102100033985 Heterogeneous nuclear ribonucleoprotein D0 Human genes 0.000 description 2
- 102100028798 Homeodomain-only protein Human genes 0.000 description 2
- 101710100605 Homeodomain-only protein Proteins 0.000 description 2
- 101000672453 Homo sapiens 60S ribosomal protein L32 Proteins 0.000 description 2
- 101000924727 Homo sapiens Alternative prion protein Proteins 0.000 description 2
- 101000924474 Homo sapiens Annexin A2 Proteins 0.000 description 2
- 101000740545 Homo sapiens BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like Proteins 0.000 description 2
- 101000910988 Homo sapiens Cathepsin W Proteins 0.000 description 2
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 2
- 101000931227 Homo sapiens DnaJ homolog subfamily A member 1 Proteins 0.000 description 2
- 101000979544 Homo sapiens Glycylpeptide N-tetradecanoyltransferase 2 Proteins 0.000 description 2
- 101000930800 Homo sapiens HLA class II histocompatibility antigen, DQ beta 1 chain Proteins 0.000 description 2
- 101001037968 Homo sapiens Heat shock 70 kDa protein 1B Proteins 0.000 description 2
- 101000866478 Homo sapiens Heat shock protein 105 kDa Proteins 0.000 description 2
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 2
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 2
- 101000573901 Homo sapiens Major prion protein Proteins 0.000 description 2
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 description 2
- 101000988407 Homo sapiens PDZ and LIM domain protein 2 Proteins 0.000 description 2
- 101000711928 Homo sapiens RING finger protein 11 Proteins 0.000 description 2
- 101001130305 Homo sapiens Ras-related protein Rab-23 Proteins 0.000 description 2
- 101001075458 Homo sapiens Regulator of G-protein signaling 16 Proteins 0.000 description 2
- 101000621041 Homo sapiens Retinoblastoma-like protein 2 Proteins 0.000 description 2
- 101000692943 Homo sapiens Ribonuclease K6 Proteins 0.000 description 2
- 101000617830 Homo sapiens Sterol O-acyltransferase 1 Proteins 0.000 description 2
- 101001038317 Homo sapiens VIP36-like protein Proteins 0.000 description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
- 102100026211 Immunoglobulin heavy constant delta Human genes 0.000 description 2
- 101710141123 Immunoglobulin heavy constant delta Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102100022338 Integrin alpha-M Human genes 0.000 description 2
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 102000043136 MAP kinase family Human genes 0.000 description 2
- 108091054455 MAP kinase family Proteins 0.000 description 2
- 101150039798 MYC gene Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 108091022875 Microtubule Proteins 0.000 description 2
- 102000029749 Microtubule Human genes 0.000 description 2
- 108020000002 NR3 subfamily Proteins 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 238000009004 PCR Kit Methods 0.000 description 2
- 102100029176 PDZ and LIM domain protein 2 Human genes 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 102100034627 Phospholipid scramblase 1 Human genes 0.000 description 2
- 101710149609 Phospholipid scramblase 1 Proteins 0.000 description 2
- 102000054291 Phox homology Human genes 0.000 description 2
- 108700035387 Phox homology Proteins 0.000 description 2
- 108010004729 Phycoerythrin Proteins 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 108010090920 Proto-Oncogene Proteins c-bcl-6 Proteins 0.000 description 2
- 108010018070 Proto-Oncogene Proteins c-ets Proteins 0.000 description 2
- 102000004053 Proto-Oncogene Proteins c-ets Human genes 0.000 description 2
- 102000009572 RNA Polymerase II Human genes 0.000 description 2
- 108010009460 RNA Polymerase II Proteins 0.000 description 2
- 102100031522 Ras-related protein Rab-23 Human genes 0.000 description 2
- 201000000582 Retinoblastoma Diseases 0.000 description 2
- 108050002651 Retinoblastoma-like protein 2 Proteins 0.000 description 2
- 102100026386 Ribonuclease K6 Human genes 0.000 description 2
- 230000018199 S phase Effects 0.000 description 2
- 102100022378 Sorting nexin-2 Human genes 0.000 description 2
- 102100021993 Sterol O-acyltransferase 1 Human genes 0.000 description 2
- 101000697584 Streptomyces lavendulae Streptothricin acetyltransferase Proteins 0.000 description 2
- 230000006044 T cell activation Effects 0.000 description 2
- 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 description 2
- 102100024547 Tensin-1 Human genes 0.000 description 2
- 108010088950 Tensins Proteins 0.000 description 2
- 102100039189 Transcription factor Maf Human genes 0.000 description 2
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 2
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 102100040248 VIP36-like protein Human genes 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000010516 arginylation Effects 0.000 description 2
- 210000003567 ascitic fluid Anatomy 0.000 description 2
- 101150045006 auh gene Proteins 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 208000011803 breast fibrocystic disease Diseases 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 230000006369 cell cycle progression Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 description 2
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 210000001650 focal adhesion Anatomy 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000011223 gene expression profiling Methods 0.000 description 2
- 108020002326 glutamine synthetase Proteins 0.000 description 2
- 102000005396 glutamine synthetase Human genes 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000005096 hematological system Anatomy 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 210000003712 lysosome Anatomy 0.000 description 2
- 230000001868 lysosomic effect Effects 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000010208 microarray analysis Methods 0.000 description 2
- 210000003632 microfilament Anatomy 0.000 description 2
- 210000004688 microtubule Anatomy 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000002297 mitogenic effect Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 201000010879 mucinous adenocarcinoma Diseases 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 102000006255 nuclear receptors Human genes 0.000 description 2
- 108020004017 nuclear receptors Proteins 0.000 description 2
- 238000002966 oligonucleotide array Methods 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 108010005636 polypeptide C Proteins 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical group CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 108010065559 rab3 GTP-Binding Proteins Proteins 0.000 description 2
- 102000013139 rab3 GTP-Binding Proteins Human genes 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 229940037128 systemic glucocorticoids Drugs 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 108091006107 transcriptional repressors Proteins 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- MSTNYGQPCMXVAQ-RYUDHWBXSA-L (6S)-5,6,7,8-tetrahydrofolate(2-) Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-L 0.000 description 1
- 108091064702 1 family Proteins 0.000 description 1
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 1
- CDKIEBFIMCSCBB-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one;hydrochloride Chemical compound Cl.C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)C=CC(C1=CC=CN=C1N1C)=C1C1=CC=CC=C1 CDKIEBFIMCSCBB-UHFFFAOYSA-N 0.000 description 1
- 102100036506 11-beta-hydroxysteroid dehydrogenase 1 Human genes 0.000 description 1
- 108091074834 12 family Proteins 0.000 description 1
- 102100030489 15-hydroxyprostaglandin dehydrogenase [NAD(+)] Human genes 0.000 description 1
- 101710141733 15-hydroxyprostaglandin dehydrogenase [NAD(+)] Proteins 0.000 description 1
- 101150028074 2 gene Proteins 0.000 description 1
- 102100027621 2'-5'-oligoadenylate synthase 2 Human genes 0.000 description 1
- 102000009878 3-Hydroxysteroid Dehydrogenases Human genes 0.000 description 1
- 102100038686 5'-nucleotidase domain-containing protein 2 Human genes 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 101150110839 Acot7 gene Proteins 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 108010085371 Activating Transcription Factor 3 Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108010058060 Alanine-tRNA ligase Proteins 0.000 description 1
- 102100037399 Alanine-tRNA ligase, cytoplasmic Human genes 0.000 description 1
- 102100039075 Aldehyde dehydrogenase family 1 member A3 Human genes 0.000 description 1
- 101710192173 Aldehyde dehydrogenase family 1 member A3 Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 201000002434 Alpha-thalassemia-X-linked intellectual disability syndrome Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 102100040894 Amylo-alpha-1,6-glucosidase Human genes 0.000 description 1
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 1
- 102000000412 Annexin Human genes 0.000 description 1
- 108050008874 Annexin Proteins 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 102000009333 Apolipoprotein D Human genes 0.000 description 1
- 108010025614 Apolipoproteins D Proteins 0.000 description 1
- 102000004363 Aquaporin 3 Human genes 0.000 description 1
- 108090000991 Aquaporin 3 Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 101000640990 Arabidopsis thaliana Tryptophan-tRNA ligase, chloroplastic/mitochondrial Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102100023927 Asparagine synthetase [glutamine-hydrolyzing] Human genes 0.000 description 1
- 108010070255 Aspartate-ammonia ligase Proteins 0.000 description 1
- 102100027936 Attractin Human genes 0.000 description 1
- 101710134735 Attractin Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
- 101710111825 B-cell lymphoma 6 protein Proteins 0.000 description 1
- 102100035745 BRD4-interacting chromatin-remodeling complex-associated protein-like Human genes 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 108010001572 Basic-Leucine Zipper Transcription Factors Proteins 0.000 description 1
- 102000000806 Basic-Leucine Zipper Transcription Factors Human genes 0.000 description 1
- 208000009299 Benign Mucous Membrane Pemphigoid Diseases 0.000 description 1
- 102100037674 Bis(5'-adenosyl)-triphosphatase Human genes 0.000 description 1
- 101100284398 Bos taurus BoLA-DQB gene Proteins 0.000 description 1
- 101710113502 Branchpoint-bridging protein Proteins 0.000 description 1
- 206010055113 Breast cancer metastatic Diseases 0.000 description 1
- 108010008629 CA-125 Antigen Proteins 0.000 description 1
- 102100025222 CD63 antigen Human genes 0.000 description 1
- 229940126074 CDK kinase inhibitor Drugs 0.000 description 1
- 108010013423 CMPacetylneuraminate monooxygenase Proteins 0.000 description 1
- 102100040805 CREB/ATF bZIP transcription factor Human genes 0.000 description 1
- 101710127422 CREB/ATF bZIP transcription factor Proteins 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 101100478890 Caenorhabditis elegans smo-1 gene Proteins 0.000 description 1
- 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101150090188 Cdk8 gene Proteins 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102100026772 Cell cycle control protein 50A Human genes 0.000 description 1
- 102100036179 Centrosomal protein of 170 kDa Human genes 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 102100026343 Charged multivesicular body protein 5 Human genes 0.000 description 1
- 101710153995 Charged multivesicular body protein 5 Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- PHEDXBVPIONUQT-UHFFFAOYSA-N Cocarcinogen A1 Natural products CCCCCCCCCCCCCC(=O)OC1C(C)C2(O)C3C=C(C)C(=O)C3(O)CC(CO)=CC2C2C1(OC(C)=O)C2(C)C PHEDXBVPIONUQT-UHFFFAOYSA-N 0.000 description 1
- 101710173933 Cohesin subunit SA-2 Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 241001101077 Crex Species 0.000 description 1
- 102100023032 Cyclic AMP-dependent transcription factor ATF-3 Human genes 0.000 description 1
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 1
- 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 1
- 102100024456 Cyclin-dependent kinase 8 Human genes 0.000 description 1
- 102100034770 Cyclin-dependent kinase inhibitor 3 Human genes 0.000 description 1
- 101710168055 Cytidine monophosphate-N-acetylneuraminic acid hydroxylase Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102100037579 D-3-phosphoglycerate dehydrogenase Human genes 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102100024829 DNA polymerase delta catalytic subunit Human genes 0.000 description 1
- 102100033484 DNA repair and recombination protein RAD54-like Human genes 0.000 description 1
- 101710179332 DNA repair and recombination protein RAD54-like Proteins 0.000 description 1
- 102100039116 DNA repair protein RAD50 Human genes 0.000 description 1
- 102100034001 DNA replication licensing factor MCM5 Human genes 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 102100027642 DNA-binding protein inhibitor ID-2 Human genes 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 102100032501 Death-inducer obliterator 1 Human genes 0.000 description 1
- 101710081796 Death-inducer obliterator 1 Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102100034274 Diamine acetyltransferase 1 Human genes 0.000 description 1
- 102100022334 Dihydropyrimidine dehydrogenase [NADP(+)] Human genes 0.000 description 1
- 108010066455 Dihydrouracil Dehydrogenase (NADP) Proteins 0.000 description 1
- 108091066263 DnaJ family Proteins 0.000 description 1
- 102000039201 DnaJ family Human genes 0.000 description 1
- 102100035966 DnaJ homolog subfamily A member 2 Human genes 0.000 description 1
- 102100023316 DnaJ homolog subfamily B member 14 Human genes 0.000 description 1
- 102100035425 DnaJ homolog subfamily B member 6 Human genes 0.000 description 1
- 101100285518 Drosophila melanogaster how gene Proteins 0.000 description 1
- 102100031290 E3 UFM1-protein ligase 1 Human genes 0.000 description 1
- 101710168832 E3 ubiquitin-protein ligase MARCHF7 Proteins 0.000 description 1
- 102100022404 E3 ubiquitin-protein ligase Midline-1 Human genes 0.000 description 1
- 102100040573 ELL-associated factor 2 Human genes 0.000 description 1
- 101710194881 ELL-associated factor 2 Proteins 0.000 description 1
- 102100021717 Early growth response protein 3 Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000005431 Endometrioid Carcinoma Diseases 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 108010014863 Eukaryotic Initiation Factors Proteins 0.000 description 1
- 102000002241 Eukaryotic Initiation Factors Human genes 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- 102100037338 F-box/LRR-repeat protein 5 Human genes 0.000 description 1
- 101710083634 F-box/LRR-repeat protein 5 Proteins 0.000 description 1
- 102100028066 F-box/LRR-repeat protein 8 Human genes 0.000 description 1
- 102100029595 Fatty acyl-CoA reductase 2 Human genes 0.000 description 1
- 208000000571 Fibrocystic breast disease Diseases 0.000 description 1
- 240000008168 Ficus benjamina Species 0.000 description 1
- 235000012571 Ficus glomerata Nutrition 0.000 description 1
- 240000000365 Ficus racemosa Species 0.000 description 1
- 102100038651 Four and a half LIM domains protein 1 Human genes 0.000 description 1
- 230000004707 G1/S transition Effects 0.000 description 1
- 102100037858 G1/S-specific cyclin-E1 Human genes 0.000 description 1
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
- 102100029974 GTPase HRas Human genes 0.000 description 1
- 102000018898 GTPase-Activating Proteins Human genes 0.000 description 1
- 108010027920 GTPase-Activating Proteins Proteins 0.000 description 1
- 108091006109 GTPases Proteins 0.000 description 1
- 230000010558 Gene Alterations Effects 0.000 description 1
- 208000034951 Genetic Translocation Diseases 0.000 description 1
- 208000031448 Genomic Instability Diseases 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 description 1
- 108010058102 Glycogen Debranching Enzyme System Proteins 0.000 description 1
- 102000017475 Glycogen debranching enzyme Human genes 0.000 description 1
- 208000032008 Glycogen storage disease due to glycogen debranching enzyme deficiency Diseases 0.000 description 1
- 206010053250 Glycogen storage disease type III Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102100034125 Golgin subfamily A member 8A Human genes 0.000 description 1
- 102100035944 HERV-H LTR-associating protein 3 Human genes 0.000 description 1
- 102100029966 HLA class II histocompatibility antigen, DP alpha 1 chain Human genes 0.000 description 1
- 102100040482 HLA class II histocompatibility antigen, DR beta 3 chain Human genes 0.000 description 1
- 101710155787 HLA class II histocompatibility antigen, DR beta 3 chain Proteins 0.000 description 1
- 108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 description 1
- 102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 description 1
- 102100040352 Heat shock 70 kDa protein 1A Human genes 0.000 description 1
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 102100035961 Hematopoietically-expressed homeobox protein HHEX Human genes 0.000 description 1
- 108010085241 Heterogeneous-Nuclear Ribonucleoprotein D Proteins 0.000 description 1
- 102100034533 Histone H2AX Human genes 0.000 description 1
- 101000928753 Homo sapiens 11-beta-hydroxysteroid dehydrogenase 1 Proteins 0.000 description 1
- 101001008910 Homo sapiens 2'-5'-oligoadenylate synthase 2 Proteins 0.000 description 1
- 101000604533 Homo sapiens 5'-nucleotidase domain-containing protein 2 Proteins 0.000 description 1
- 101000893559 Homo sapiens Amylo-alpha-1,6-glucosidase Proteins 0.000 description 1
- 101000823051 Homo sapiens Amyloid-beta precursor protein Proteins 0.000 description 1
- 101000802808 Homo sapiens BRD4-interacting chromatin-remodeling complex-associated protein-like Proteins 0.000 description 1
- 101001027506 Homo sapiens Bis(5'-adenosyl)-triphosphatase Proteins 0.000 description 1
- 101000910814 Homo sapiens Cell cycle control protein 50A Proteins 0.000 description 1
- 101000715694 Homo sapiens Centrosomal protein of 170 kDa Proteins 0.000 description 1
- 101000642968 Homo sapiens Cohesin subunit SA-2 Proteins 0.000 description 1
- 101000910484 Homo sapiens Cyclin-T2 Proteins 0.000 description 1
- 101000868333 Homo sapiens Cyclin-dependent kinase 1 Proteins 0.000 description 1
- 101000980937 Homo sapiens Cyclin-dependent kinase 8 Proteins 0.000 description 1
- 101000945639 Homo sapiens Cyclin-dependent kinase inhibitor 3 Proteins 0.000 description 1
- 101000909198 Homo sapiens DNA polymerase delta catalytic subunit Proteins 0.000 description 1
- 101000743929 Homo sapiens DNA repair protein RAD50 Proteins 0.000 description 1
- 101001017545 Homo sapiens DNA replication licensing factor MCM5 Proteins 0.000 description 1
- 101001081582 Homo sapiens DNA-binding protein inhibitor ID-2 Proteins 0.000 description 1
- 101000641077 Homo sapiens Diamine acetyltransferase 1 Proteins 0.000 description 1
- 101000908034 Homo sapiens DnaJ homolog subfamily B member 14 Proteins 0.000 description 1
- 101000804112 Homo sapiens DnaJ homolog subfamily B member 6 Proteins 0.000 description 1
- 101000870166 Homo sapiens DnaJ homolog subfamily C member 14 Proteins 0.000 description 1
- 101000680670 Homo sapiens E3 ubiquitin-protein ligase Midline-1 Proteins 0.000 description 1
- 101000896450 Homo sapiens Early growth response protein 3 Proteins 0.000 description 1
- 101001060250 Homo sapiens F-box/LRR-repeat protein 8 Proteins 0.000 description 1
- 101000917301 Homo sapiens Fatty acyl-CoA reductase 2 Proteins 0.000 description 1
- 101001031607 Homo sapiens Four and a half LIM domains protein 1 Proteins 0.000 description 1
- 101000738568 Homo sapiens G1/S-specific cyclin-E1 Proteins 0.000 description 1
- 101000584633 Homo sapiens GTPase HRas Proteins 0.000 description 1
- 101001070493 Homo sapiens Golgin subfamily A member 8A Proteins 0.000 description 1
- 101001040751 Homo sapiens Granulysin Proteins 0.000 description 1
- 101001021492 Homo sapiens HERV-H LTR-associating protein 3 Proteins 0.000 description 1
- 101000864089 Homo sapiens HLA class II histocompatibility antigen, DP alpha 1 chain Proteins 0.000 description 1
- 101001037759 Homo sapiens Heat shock 70 kDa protein 1A Proteins 0.000 description 1
- 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 description 1
- 101001021503 Homo sapiens Hematopoietically-expressed homeobox protein HHEX Proteins 0.000 description 1
- 101001017535 Homo sapiens Heterogeneous nuclear ribonucleoprotein D0 Proteins 0.000 description 1
- 101001067891 Homo sapiens Histone H2AX Proteins 0.000 description 1
- 101000971797 Homo sapiens KH homology domain-containing protein 4 Proteins 0.000 description 1
- 101001138020 Homo sapiens La-related protein 4 Proteins 0.000 description 1
- 101001090484 Homo sapiens LanC-like protein 2 Proteins 0.000 description 1
- 101000619643 Homo sapiens Ligand-dependent nuclear receptor-interacting factor 1 Proteins 0.000 description 1
- 101000799318 Homo sapiens Long-chain-fatty-acid-CoA ligase 1 Proteins 0.000 description 1
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 description 1
- 101000573451 Homo sapiens Msx2-interacting protein Proteins 0.000 description 1
- 101000973778 Homo sapiens NAD(P)H dehydrogenase [quinone] 1 Proteins 0.000 description 1
- 101001091191 Homo sapiens Peptidyl-prolyl cis-trans isomerase F, mitochondrial Proteins 0.000 description 1
- 101000701367 Homo sapiens Phospholipid-transporting ATPase IA Proteins 0.000 description 1
- 101000615933 Homo sapiens Phosphoserine aminotransferase Proteins 0.000 description 1
- 101000595674 Homo sapiens Pituitary homeobox 3 Proteins 0.000 description 1
- 101001041721 Homo sapiens Probable ATP-dependent RNA helicase DDX17 Proteins 0.000 description 1
- 101000822478 Homo sapiens Protein transport protein Sec31B Proteins 0.000 description 1
- 101001081576 Homo sapiens Putative DNA-binding protein inhibitor ID-2B Proteins 0.000 description 1
- 101000797874 Homo sapiens Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 Proteins 0.000 description 1
- 101000996935 Homo sapiens Putative oxidoreductase GLYR1 Proteins 0.000 description 1
- 101000689365 Homo sapiens Pyridoxal phosphate homeostasis protein Proteins 0.000 description 1
- 101000576060 Homo sapiens RAD50-interacting protein 1 Proteins 0.000 description 1
- 101000620773 Homo sapiens Ras GTPase-activating protein 3 Proteins 0.000 description 1
- 101000686225 Homo sapiens Ras-related GTP-binding protein D Proteins 0.000 description 1
- 101000620554 Homo sapiens Ras-related protein Rab-38 Proteins 0.000 description 1
- 101001130433 Homo sapiens Ras-related protein Rap-2c Proteins 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 101000704874 Homo sapiens Rho family-interacting cell polarization regulator 2 Proteins 0.000 description 1
- 101000633778 Homo sapiens SLAM family member 5 Proteins 0.000 description 1
- 101000828739 Homo sapiens SPATS2-like protein Proteins 0.000 description 1
- 101000936917 Homo sapiens Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 Proteins 0.000 description 1
- 101001040808 Homo sapiens Serine hydroxymethyltransferase, cytosolic Proteins 0.000 description 1
- 101000741917 Homo sapiens Serine/threonine-protein phosphatase 1 regulatory subunit 10 Proteins 0.000 description 1
- 101000789523 Homo sapiens Sodium/potassium-transporting ATPase subunit beta-1 Proteins 0.000 description 1
- 101000824954 Homo sapiens Sorting nexin-2 Proteins 0.000 description 1
- 101000628501 Homo sapiens StAR-related lipid transfer protein 5 Proteins 0.000 description 1
- 101000666730 Homo sapiens T-complex protein 1 subunit alpha Proteins 0.000 description 1
- 101000626153 Homo sapiens Tensin-3 Proteins 0.000 description 1
- 101000633680 Homo sapiens Tetratricopeptide repeat protein 37 Proteins 0.000 description 1
- 101000904152 Homo sapiens Transcription factor E2F1 Proteins 0.000 description 1
- 101000904150 Homo sapiens Transcription factor E2F3 Proteins 0.000 description 1
- 101000904868 Homo sapiens Transcriptional regulator ATRX Proteins 0.000 description 1
- 101000713936 Homo sapiens Tudor domain-containing protein 7 Proteins 0.000 description 1
- 101000992235 Homo sapiens UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase 110 kDa subunit Proteins 0.000 description 1
- 101100155298 Homo sapiens UFL1 gene Proteins 0.000 description 1
- 101000614277 Homo sapiens Ubiquitin thioesterase OTUB1 Proteins 0.000 description 1
- 101000662278 Homo sapiens Ubiquitin-like protein 3 Proteins 0.000 description 1
- 101001000119 Homo sapiens Unconventional myosin-If Proteins 0.000 description 1
- 101000997307 Homo sapiens Voltage-gated potassium channel subunit beta-2 Proteins 0.000 description 1
- 101000854908 Homo sapiens WD repeat-containing protein 11 Proteins 0.000 description 1
- 101000818605 Homo sapiens Zinc finger and BTB domain-containing protein 32 Proteins 0.000 description 1
- 101000730643 Homo sapiens Zinc finger protein PLAGL1 Proteins 0.000 description 1
- 101000785641 Homo sapiens Zinc finger protein with KRAB and SCAN domains 1 Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 108010044240 IFIH1 Interferon-Induced Helicase Proteins 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 102100029616 Immunoglobulin lambda-like polypeptide 1 Human genes 0.000 description 1
- 101710107067 Immunoglobulin lambda-like polypeptide 1 Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 1
- 101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 description 1
- 102000007576 Interferon Regulatory Factor-7 Human genes 0.000 description 1
- 108010032036 Interferon Regulatory Factor-7 Proteins 0.000 description 1
- 102100027353 Interferon-induced helicase C domain-containing protein 1 Human genes 0.000 description 1
- 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
- 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
- 102100021449 KH homology domain-containing protein 4 Human genes 0.000 description 1
- 238000012313 Kruskal-Wallis test Methods 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102100020861 La-related protein 4 Human genes 0.000 description 1
- 102100034723 LanC-like protein 2 Human genes 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 102100022172 Ligand-dependent nuclear receptor-interacting factor 1 Human genes 0.000 description 1
- 208000000265 Lobular Carcinoma Diseases 0.000 description 1
- 102100033995 Long-chain-fatty-acid-CoA ligase 1 Human genes 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 102100033486 Lymphocyte antigen 75 Human genes 0.000 description 1
- 101710157884 Lymphocyte antigen 75 Proteins 0.000 description 1
- 108010009489 Lysosomal-Associated Membrane Protein 3 Proteins 0.000 description 1
- 102100033468 Lysozyme C Human genes 0.000 description 1
- 108091007340 MARCHs Proteins 0.000 description 1
- 102000043131 MHC class II family Human genes 0.000 description 1
- 108091054438 MHC class II family Proteins 0.000 description 1
- 102000039538 Maf family Human genes 0.000 description 1
- 108091067370 Maf family Proteins 0.000 description 1
- 208000004059 Male Breast Neoplasms Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102100025744 Mothers against decapentaplegic homolog 1 Human genes 0.000 description 1
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 1
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 1
- 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 1
- 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
- 102100030608 Mothers against decapentaplegic homolog 7 Human genes 0.000 description 1
- 102100026285 Msx2-interacting protein Human genes 0.000 description 1
- 102100034256 Mucin-1 Human genes 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 102100022365 NAD(P)H dehydrogenase [quinone] 1 Human genes 0.000 description 1
- 101150045905 NFAT5 gene Proteins 0.000 description 1
- 102000005238 NM23 Nucleoside Diphosphate Kinases Human genes 0.000 description 1
- 108010081372 NM23 Nucleoside Diphosphate Kinases Proteins 0.000 description 1
- 206010061309 Neoplasm progression Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 108010051791 Nuclear Antigens Proteins 0.000 description 1
- 102000019040 Nuclear Antigens Human genes 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102100036878 PHD finger protein 20 Human genes 0.000 description 1
- 108091012461 PHD finger protein 20 Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000025618 Paget disease of nipple Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 201000011152 Pemphigus Diseases 0.000 description 1
- 102100034943 Peptidyl-prolyl cis-trans isomerase F, mitochondrial Human genes 0.000 description 1
- 102100033716 Phorbol-12-myristate-13-acetate-induced protein 1 Human genes 0.000 description 1
- 101710162960 Phorbol-12-myristate-13-acetate-induced protein 1 Proteins 0.000 description 1
- 102100032287 Phosphatidylinositide phosphatase SAC2 Human genes 0.000 description 1
- 101710149053 Phosphatidylinositide phosphatase SAC2 Proteins 0.000 description 1
- 108010010677 Phosphodiesterase I Proteins 0.000 description 1
- 108010038555 Phosphoglycerate dehydrogenase Proteins 0.000 description 1
- 102000011420 Phospholipase D Human genes 0.000 description 1
- 108090000553 Phospholipase D Proteins 0.000 description 1
- 102100030622 Phospholipid-transporting ATPase IA Human genes 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102100021768 Phosphoserine aminotransferase Human genes 0.000 description 1
- 102100036088 Pituitary homeobox 3 Human genes 0.000 description 1
- 102000010995 Pleckstrin homology domains Human genes 0.000 description 1
- 108050001185 Pleckstrin homology domains Proteins 0.000 description 1
- 102100040153 Poly(A) polymerase gamma Human genes 0.000 description 1
- 101710090312 Poly(A) polymerase gamma Proteins 0.000 description 1
- 102100033073 Polypyrimidine tract-binding protein 1 Human genes 0.000 description 1
- 101710132817 Polypyrimidine tract-binding protein 1 Proteins 0.000 description 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 102100021409 Probable ATP-dependent RNA helicase DDX17 Human genes 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010078137 Protein Kinase C-epsilon Proteins 0.000 description 1
- 102100022485 Protein transport protein Sec31B Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 102100030944 Protein-glutamine gamma-glutamyltransferase K Human genes 0.000 description 1
- 101800001295 Putative ATP-dependent helicase Proteins 0.000 description 1
- 102100027635 Putative DNA-binding protein inhibitor ID-2B Human genes 0.000 description 1
- 102100032337 Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 Human genes 0.000 description 1
- 101800001006 Putative helicase Proteins 0.000 description 1
- 102100034301 Putative oxidoreductase GLYR1 Human genes 0.000 description 1
- 102100024487 Pyridoxal phosphate homeostasis protein Human genes 0.000 description 1
- 102100025895 RAD50-interacting protein 1 Human genes 0.000 description 1
- 102100023488 RAS guanyl-releasing protein 2 Human genes 0.000 description 1
- 101710144556 RAS guanyl-releasing protein 2 Proteins 0.000 description 1
- 101710119948 RING finger protein 11 Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 102000002490 Rad51 Recombinase Human genes 0.000 description 1
- 108010068097 Rad51 Recombinase Proteins 0.000 description 1
- 102100038473 Ran GTPase-activating protein 1 Human genes 0.000 description 1
- 101710160162 Ran GTPase-activating protein 1 Proteins 0.000 description 1
- 102100022879 Ras GTPase-activating protein 3 Human genes 0.000 description 1
- 102100025002 Ras-related GTP-binding protein D Human genes 0.000 description 1
- 102100022305 Ras-related protein Rab-38 Human genes 0.000 description 1
- 102100031422 Ras-related protein Rap-2c Human genes 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 108091027981 Response element Proteins 0.000 description 1
- 102100038042 Retinoblastoma-associated protein Human genes 0.000 description 1
- 101710124357 Retinoblastoma-associated protein Proteins 0.000 description 1
- 102100034634 Reversion-inducing cysteine-rich protein with Kazal motifs Human genes 0.000 description 1
- 101710104618 Reversion-inducing cysteine-rich protein with Kazal motifs Proteins 0.000 description 1
- 102100025642 Rho GDP-dissociation inhibitor 1 Human genes 0.000 description 1
- 102100032023 Rho family-interacting cell polarization regulator 2 Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 108090000878 Ribosomal protein S9 Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 101000744001 Ruminococcus gnavus (strain ATCC 29149 / VPI C7-9) 3beta-hydroxysteroid dehydrogenase Proteins 0.000 description 1
- 102000014400 SH2 domains Human genes 0.000 description 1
- 108050003452 SH2 domains Proteins 0.000 description 1
- 102100029216 SLAM family member 5 Human genes 0.000 description 1
- 101700032040 SMAD1 Proteins 0.000 description 1
- 101700026522 SMAD7 Proteins 0.000 description 1
- 101150102102 SMT3 gene Proteins 0.000 description 1
- 102100023521 SPATS2-like protein Human genes 0.000 description 1
- 101150096255 SUMO1 gene Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 102100027733 Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 Human genes 0.000 description 1
- 101100408688 Schizosaccharomyces pombe (strain 972 / ATCC 24843) pmt3 gene Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 1
- 102100038743 Serine/threonine-protein phosphatase 1 regulatory subunit 10 Human genes 0.000 description 1
- 208000003252 Signet Ring Cell Carcinoma Diseases 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 102100026940 Small ubiquitin-related modifier 1 Human genes 0.000 description 1
- 101710081623 Small ubiquitin-related modifier 1 Proteins 0.000 description 1
- 102100028844 Sodium/potassium-transporting ATPase subunit beta-1 Human genes 0.000 description 1
- 102000005045 Sorting Nexin Human genes 0.000 description 1
- 101710103884 Sorting nexin-2 Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 101710153291 Splicing factor 1 Proteins 0.000 description 1
- 102100030056 Splicing factor 1 Human genes 0.000 description 1
- 102100026709 StAR-related lipid transfer protein 5 Human genes 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 108700027336 Suppressor of Cytokine Signaling 1 Proteins 0.000 description 1
- 102100024779 Suppressor of cytokine signaling 1 Human genes 0.000 description 1
- 102100021701 Switch-associated protein 70 Human genes 0.000 description 1
- 101710149524 Switch-associated protein 70 Proteins 0.000 description 1
- 102100038410 T-complex protein 1 subunit alpha Human genes 0.000 description 1
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 1
- 102000042631 TRIM/RBCC family Human genes 0.000 description 1
- 108091053398 TRIM/RBCC family Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 102100034915 Tetraspanin-32 Human genes 0.000 description 1
- 101710132098 Tetraspanin-32 Proteins 0.000 description 1
- 102100029210 Tetratricopeptide repeat protein 37 Human genes 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical compound OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 102000008229 Toll-like receptor 1 Human genes 0.000 description 1
- 108010060889 Toll-like receptor 1 Proteins 0.000 description 1
- 102100024026 Transcription factor E2F1 Human genes 0.000 description 1
- 102100024027 Transcription factor E2F3 Human genes 0.000 description 1
- 108050004365 Transcription factor Maf Proteins 0.000 description 1
- 102100023931 Transcriptional regulator ATRX Human genes 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108010033576 Transferrin Receptors Proteins 0.000 description 1
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
- 102000002501 Tryptophan-tRNA Ligase Human genes 0.000 description 1
- 102100036455 Tudor domain-containing protein 7 Human genes 0.000 description 1
- 102100031929 UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase 110 kDa subunit Human genes 0.000 description 1
- 102100040461 Ubiquitin thioesterase OTUB1 Human genes 0.000 description 1
- 102100037847 Ubiquitin-like protein 3 Human genes 0.000 description 1
- 102100035825 Unconventional myosin-If Human genes 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 102100034074 Voltage-gated potassium channel subunit beta-2 Human genes 0.000 description 1
- 102100020705 WD repeat-containing protein 11 Human genes 0.000 description 1
- 201000006035 X-linked dominant hypophosphatemic rickets Diseases 0.000 description 1
- 102100039488 XIAP-associated factor 1 Human genes 0.000 description 1
- 101710199425 XIAP-associated factor 1 Proteins 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 102100040762 Zinc finger and BTB domain-containing protein 18 Human genes 0.000 description 1
- 101710096156 Zinc finger and BTB domain-containing protein 18 Proteins 0.000 description 1
- 102100021135 Zinc finger and BTB domain-containing protein 32 Human genes 0.000 description 1
- 102100036595 Zinc finger protein 217 Human genes 0.000 description 1
- 101710144144 Zinc finger protein 217 Proteins 0.000 description 1
- 102100040639 Zinc finger protein 83 Human genes 0.000 description 1
- 101710160490 Zinc finger protein 83 Proteins 0.000 description 1
- 102100032570 Zinc finger protein PLAGL1 Human genes 0.000 description 1
- 102100026463 Zinc finger protein with KRAB and SCAN domains 1 Human genes 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000002517 adenoid cystic carcinoma Diseases 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 230000003305 autocrine Effects 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 230000002358 autolytic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000009287 biochemical signal transduction Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 201000003149 breast fibroadenoma Diseases 0.000 description 1
- 201000003714 breast lobular carcinoma Diseases 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000025084 cell cycle arrest Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000003021 clonogenic effect Effects 0.000 description 1
- 108010045512 cohesins Proteins 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 210000002726 cyst fluid Anatomy 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000005220 cytoplasmic tail Anatomy 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011334 debulking surgery Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
- 208000022602 disease susceptibility Diseases 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 208000028730 endometrioid adenocarcinoma Diseases 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000000267 erythroid cell Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 210000003002 eukaryotic large ribosome subunit Anatomy 0.000 description 1
- 210000004265 eukaryotic small ribosome subunit Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000028023 exocytosis Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 201000006061 fatal familial insomnia Diseases 0.000 description 1
- 208000028149 female reproductive system neoplasm Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000007045 gastrulation Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 201000004543 glycogen storage disease III Diseases 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000013210 hematogenous Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 208000021991 hereditary neoplastic syndrome Diseases 0.000 description 1
- 238000010842 high-capacity cDNA reverse transcription kit Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 102000052634 human SHMT Human genes 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006058 immune tolerance Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000005007 innate immune system Anatomy 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 206010073096 invasive lobular breast carcinoma Diseases 0.000 description 1
- 230000019948 ion homeostasis Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 238000002789 length control Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- YAFQFNOUYXZVPZ-UHFFFAOYSA-N liproxstatin-1 Chemical compound ClC1=CC=CC(CNC=2C3(CCNCC3)NC3=CC=CC=C3N=2)=C1 YAFQFNOUYXZVPZ-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000003175 male breast cancer Diseases 0.000 description 1
- 208000010907 male breast carcinoma Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000027202 mammary Paget disease Diseases 0.000 description 1
- 238000009607 mammography Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030163 medullary breast carcinoma Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 108010009759 methylglutaconyl-CoA hydratase Proteins 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000004879 molecular function Effects 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 108700024542 myc Genes Proteins 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 201000003631 narcolepsy Diseases 0.000 description 1
- 230000032929 negative regulation of cell cycle Effects 0.000 description 1
- 201000002120 neuroendocrine carcinoma Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 230000037434 nonsense mutation Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 108091008607 nuclear receptor subfamilies Proteins 0.000 description 1
- 102000027419 nuclear receptor subfamilies Human genes 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 230000006849 nucleocytoplasmic transport Effects 0.000 description 1
- 230000030648 nucleus localization Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 208000015200 ocular cicatricial pemphigoid Diseases 0.000 description 1
- 102000027450 oncoproteins Human genes 0.000 description 1
- 108091008819 oncoproteins Proteins 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 201000010198 papillary carcinoma Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 201000001976 pemphigus vulgaris Diseases 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 108010037555 polypeptide 1 70kD ribosomal protein S6 kinase Proteins 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 210000004908 prostatic fluid Anatomy 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000012755 real-time RT-PCR analysis Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000013643 reference control Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000028617 response to DNA damage stimulus Effects 0.000 description 1
- 108010084871 rho Guanine Nucleotide Dissociation Inhibitor alpha Proteins 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 102000004413 ribosomal protein S11 Human genes 0.000 description 1
- 108090000930 ribosomal protein S11 Proteins 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 201000007416 salivary gland adenoid cystic carcinoma Diseases 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 108010052031 septide Proteins 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 201000008123 signet ring cell adenocarcinoma Diseases 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 238000011524 similarity measure Methods 0.000 description 1
- 230000018381 sister chromatid cohesion Effects 0.000 description 1
- 102000030938 small GTPase Human genes 0.000 description 1
- 108060007624 small GTPase Proteins 0.000 description 1
- 208000000649 small cell carcinoma Diseases 0.000 description 1
- 230000008410 smoothened signaling pathway Effects 0.000 description 1
- YEENEYXBHNNNGV-XEHWZWQGSA-M sodium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoate;(2r,3r,4s,5s,6r)-2-[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound [Na+].CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I.O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YEENEYXBHNNNGV-XEHWZWQGSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 108060007774 sorting nexin Proteins 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 201000010700 sporadic breast cancer Diseases 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 108700026239 src Genes Proteins 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 102000005969 steroid hormone receptors Human genes 0.000 description 1
- 108020003113 steroid hormone receptors Proteins 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 102000000580 synaptojanin Human genes 0.000 description 1
- 108010016910 synaptojanin Proteins 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 102000004217 thyroid hormone receptors Human genes 0.000 description 1
- 108090000721 thyroid hormone receptors Proteins 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 206010044412 transitional cell carcinoma Diseases 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000005747 tumor angiogenesis Effects 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 230000005751 tumor progression Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 108091005990 tyrosine-phosphorylated proteins Proteins 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000028973 vesicle-mediated transport Effects 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL184478 | 2007-07-08 | ||
IL184478A IL184478A (en) | 2007-07-08 | 2007-07-08 | Preparations, methods and kits for identifying carriers of mutations in genes 1brca and 2brca and for the early detection of cancers associated with mutations in these genes |
PCT/IL2008/000934 WO2009007958A2 (fr) | 2007-07-08 | 2008-07-08 | Compositions, procédés et trousses pour le diagnostic de transporteurs de mutations dans les gènes brca1 et brca2 et le diagnostic précoce de troubles cancéreux associés à des mutations dans les gènes brca1 et brca2 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2692803A1 true CA2692803A1 (fr) | 2009-01-15 |
Family
ID=40229201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2692803 Abandoned CA2692803A1 (fr) | 2007-07-08 | 2008-07-08 | Compositions, procedes et trousses pour le diagnostic de transporteurs de mutations dans les genes brca1 et brca2 et le diagnostic precoce de troubles cancereux associes a des mutations dans les genes brca1 et brca2 |
Country Status (5)
Country | Link |
---|---|
US (3) | US20100267569A1 (fr) |
EP (1) | EP2176424A2 (fr) |
CA (1) | CA2692803A1 (fr) |
IL (1) | IL184478A (fr) |
WO (1) | WO2009007958A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113151296A (zh) * | 2021-03-22 | 2021-07-23 | 云南中烟工业有限责任公司 | 一种烟草热激蛋白相关的基因及其应用 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010123818A1 (fr) * | 2009-04-20 | 2010-10-28 | Medical College Of Georgia Research Institute, Inc. | Gène gt198 de prédisposition au cancer du sein et ses utilisations |
US20140296281A1 (en) * | 2011-11-25 | 2014-10-02 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for screening a brca1 loss-of-function in a subject suffering from a cancer |
KR20220123754A (ko) | 2013-12-20 | 2022-09-08 | 뉴리뮨 홀딩 아게 | 트랜스티레틴(ttr) 아밀로이드증의 항체-기반의 치료 및 이를 위한 인간-유래의 항체 |
BR112017002884A2 (pt) | 2014-08-14 | 2018-01-30 | Memed Diagnostics Ltd | ?análise computacional de dados biológicos por meio do uso de variedade e hiperplano? |
EP3423589B1 (fr) | 2016-03-03 | 2021-07-21 | Memed Diagnostics Ltd. | Analyse d'arn pour diagnostiquer un type d'infection |
WO2017149548A1 (fr) | 2016-03-03 | 2017-09-08 | Memed Diagnostics Ltd. | Déterminants d'arn pour différencier des infections bactériennes d'infections virales |
CN105586427B (zh) * | 2016-03-10 | 2020-06-19 | 厦门艾德生物医药科技股份有限公司 | 检测人类brca1和brca2基因突变的引物、试剂盒及方法 |
US10733214B2 (en) | 2017-03-20 | 2020-08-04 | International Business Machines Corporation | Analyzing metagenomics data |
WO2022258252A1 (fr) * | 2021-06-08 | 2022-12-15 | Medizinische Universität Innsbruck | Biomarqueur de surveillance de maladie de coronavirus 2019 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
US5538848A (en) * | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
DE69610304T2 (de) * | 1995-05-05 | 2001-04-05 | Perkin Elmer Corp | Methoden and reagentien fuer die kombination einer pcr-amplifizierung mit einem hybridisierungs-assay |
US5736333A (en) * | 1996-06-04 | 1998-04-07 | The Perkin-Elmer Corporation | Passive internal references for the detection of nucleic acid amplification products |
US5866336A (en) * | 1996-07-16 | 1999-02-02 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
US5952202A (en) * | 1998-03-26 | 1999-09-14 | The Perkin Elmer Corporation | Methods using exogenous, internal controls and analogue blocks during nucleic acid amplification |
US20050100897A1 (en) * | 2002-03-29 | 2005-05-12 | Alex Toker | NFAT transcription factors in tumor progression |
EP1758792A2 (fr) * | 2004-06-04 | 2007-03-07 | Linkagene LTD. | Procedes pour detecter l'expression genique dans des cellules du sang peripherique et utilisations de ces procedes |
WO2007067813A2 (fr) * | 2005-12-09 | 2007-06-14 | Fox Chase Cancer Center | Méthodes et compositions pour estimer des modifications dans les modeles d'expression de gène dans des tissus cliniquement normaux provenant de porteurs hétérozygotes de gènes mutants associés au cancer et leur méthodes d'utilisation |
-
2007
- 2007-07-08 IL IL184478A patent/IL184478A/en active IP Right Grant
-
2008
- 2008-07-08 CA CA 2692803 patent/CA2692803A1/fr not_active Abandoned
- 2008-07-08 WO PCT/IL2008/000934 patent/WO2009007958A2/fr active Application Filing
- 2008-07-08 US US12/668,154 patent/US20100267569A1/en not_active Abandoned
- 2008-07-08 EP EP08776587A patent/EP2176424A2/fr not_active Withdrawn
-
2015
- 2015-08-25 US US14/834,989 patent/US20150354014A1/en not_active Abandoned
-
2018
- 2018-02-14 US US15/896,902 patent/US20180187269A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113151296A (zh) * | 2021-03-22 | 2021-07-23 | 云南中烟工业有限责任公司 | 一种烟草热激蛋白相关的基因及其应用 |
CN113151296B (zh) * | 2021-03-22 | 2022-09-13 | 云南中烟工业有限责任公司 | 一种烟草热激蛋白相关的基因及其应用 |
Also Published As
Publication number | Publication date |
---|---|
US20180187269A1 (en) | 2018-07-05 |
WO2009007958A3 (fr) | 2009-07-02 |
IL184478A0 (en) | 2008-12-29 |
US20100267569A1 (en) | 2010-10-21 |
US20150354014A1 (en) | 2015-12-10 |
EP2176424A2 (fr) | 2010-04-21 |
IL184478A (en) | 2017-07-31 |
WO2009007958A2 (fr) | 2009-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180187269A1 (en) | Compositions, methods and kits for the diagnosis of carriers of mutations in the brca1 and brca2 genes and early diagnosis of cancerous disorders associated with mutations in brca1 and brca2 genes | |
US20200095642A1 (en) | Grading of breast cancer | |
EP1824997B1 (fr) | Alterations genetiques utiles pour predire la response de neoplasies malignes a des traitements medicaux bases sur le taxane | |
US20050181375A1 (en) | Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer | |
US20110166028A1 (en) | Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancers | |
US20090280493A1 (en) | Methods and Compositions for the Prediction of Response to Trastuzumab Containing Chemotherapy Regimen in Malignant Neoplasia | |
WO2002059271A2 (fr) | Profils d'expression genetique dans des tissus mammaires | |
US20080182246A1 (en) | Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis | |
CA2425569A1 (fr) | Procedes de diagnostic du cancer de la prostate, compositions et procedes de criblage de modulateurs du cancer de la prostate | |
AU2005201935B2 (en) | Prognostic for hematological malignancy | |
CA2726531A1 (fr) | Compositions et procedes pour la classification du cancer du poumon et le pronostic de survie au cancer du poumon | |
AU2005316291A1 (en) | Methods for assessing patients with acute myeloid leukemia | |
US20110151443A1 (en) | Marker for gastric cancer | |
KR101182974B1 (ko) | 림프종 진단 또는 예후 마커로서 Pellino 1 | |
KR101847815B1 (ko) | 삼중음성유방암의 아형 분류 방법 | |
US20150071947A1 (en) | Methods of identifying gene isoforms for anti-cancer treatments | |
KR101601943B1 (ko) | 난소암 환자의 항암제 치료 반응성 예측을 위한 마커 uchl1 | |
KR101583673B1 (ko) | 난소암 환자의 항암제 치료 반응성 예측을 위한 마커 dlx5 | |
EP2454388A2 (fr) | Procédés et kits utilisés dans l'évaluation du risque de cancer | |
KR102163550B1 (ko) | 방광암 검출용 소변 표지 | |
WO2007088971A1 (fr) | Groupe de genes applicable au pronostic d'un cancer | |
KR101601941B1 (ko) | 난소암 환자의 항암제 치료 반응성 예측을 위한 마커 mta3 | |
AU2012202170A1 (en) | Prognostic for hematological malignancy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20130617 |
|
FZDE | Discontinued |
Effective date: 20160609 |